Givaudan celebrates the 10th anniversary of its entry into the active cosmetic ingredients business and beauty biotechnology in Pomacle, France. Over the past decade, the biotech industrial site in Pomacle is said to have contributed to the remarkable growth and development of the Givaudan Active Beauty business.
Since its acquisition, Givaudan is said to have made significant investments in Pomacle, leveraging the exceptional human skills and capabilities in biotechnology to design, create and produce sustainably new active ingredients for the cosmetic industry, including new hero molecules around hyaluronic acid.
Kick-started with the acquisition of Soliance, Givaudan continued over the last 10 years to expand its cosmetic actives portfolio with the acquisitions of Induchem, Indena (acquisition of the cosmetics business only), Naturex and Alderys.
Gilles Andrier, CEO of Givaudan, stated, "The 10th anniversary of Soliance’s acquisition is a testament to Givaudan's dedication to continuous growth and innovation. We are proud of the achievements made at Pomacle and remain committed to investing in the development of capabilities that will further strengthen our position as the leader in biotech cosmetic ingredients."
Maurizio Volpi, president Fragrance & Beauty, said, "This acquisition has played a pivotal role in our ability to offer exceptional products coming from biotech to our customers. Indeed, the beauty market is expecting more and more sustainable and natural alternatives while keeping a high level of science and performance behind each new ingredient. And this is exactly what we are doing thanks to the team and capabilities we have in Pomacle." * Acquisition of the cosmetics business only.
